NSC 357704
Alternative Names: A 489; ADR 489; MR CN DX; MRA CNLatest Information Update: 19 May 2005
At a glance
- Originator SRI International
- Developer Adria
- Class Cytostatic antibiotics
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 19 May 2005 Discontinued for Cancer in Germany (unspecified route)
- 19 May 2005 Discontinued for Cancer in Italy (unspecified route)
- 19 May 2005 Discontinued for Cancer in USA (unspecified route)